What they were paid
Mirum Pharmaceuticals Director Compensation Table · all 2 fiscal years held| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2025 | $90,625 | $174,988 | $174,855 | $0 | $440,468 |
| FY2024 | $83,750 | $149,989 | $149,774 | — | $383,513 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Mirum Pharmaceuticals, Inc. DEF 14A filed April 23, 2026, accession 0001759425-26-000027, and prior-year filings. Open the filing on EDGAR.
How this board is paid
company policy · FY2025Mirum Pharmaceuticals pays directors a $50,000 cash retainer and $300,000 in RSUs and Options.
Committees
FY2025 · as the proxy prints themAudit (Chair) · Nominating/Governance
The rest of the Mirum Pharmaceuticals board
FY2025 · as the company reported each| Director | Role | FY2025 total |
|---|---|---|
| Christopher Peetz | Director | $0 |
| Laurent Fischer | Independent Director | $429,843 |
| Lon Cardon | Independent Director | $404,843 |
| Michael Grey | Chair of the Board | $459,843 |
| Patrick Heron | Independent Director | $409,843 |
| Saira Ramasastry | Independent Director | — |
| Timothy Walbert | Independent Director | $414,843 |
| William C. Fairey | Independent Director | $421,718 |
The full Mirum Pharmaceuticals compensation record
free company briefThis page is one director within Mirum Pharmaceuticals's record. The company brief lists every named executive and director, each linking to their own page.
Velarion Pro: every company page, peer tools and exports, one seat